Invesco Biotechnology & Genome ETF

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

Jurisdiction: USLegal Form: 8888

ACTIVE

LEI: 549300TC80GXFQLM7W73

Summary

Invesco Biotechnology & Genome ETF is an organization. It is a subsidiary of INVESCO CAPITAL MANAGEMENT LLC.

Legal entity: GLEIF